Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
The findings, published online today in Nature, describe not only a way to detect cancer, but hold promise of being able to find it earlier when it is more easily treated and long before symptoms ever appear, says Dr. De Carvalho, Senior Scientist at the cancer centre, University Health Network.
“We are very excited at this stage,” says Dr. De Carvalho. “A major problem in cancer is how to detect it early. It has been a ‘needle in the haystack’ problem of how to find that one-in-a-billion cancer-specific mutation in the blood, especially at earlier stages, where the amount of tumour DNA in the blood is minimal.”
By profiling epigenetic alterations instead of mutations, the team was able to identify thousands of modifications unique to each cancer type. Then, using a big data approach, they applied machine learning to create classifiers able to identify the presence of cancer-derived DNA within blood samples and to determine what cancer type. This basically turns the “one needle in the haystack” problem into a more solvable “thousands of needles in the haystack,” where the computer just needs to find a few needles to define which haystack has needles.
The scientists tracked the cancer origin and type by comparing 300 patient tumour samples from seven disease sites (lung, pancreatic, colorectal, breast, leukemia, bladder and kidney) and samples from healthy donors with the analysis of cell-free DNA circulating in the blood plasma. In every sample, the “floating” plasma DNA matched the tumour DNA. The team has since expanded the research and has now profiled and successfully matched more than 700 tumour and blood samples from more cancer types.
Beyond the lab, next steps to further validate this approach include analysing data from large population health research studies already under way in several countries, where blood samples were collected months to years before cancer diagnosis. Then the approach will need to be ultimately validated in prospective studies for cancer screening.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Giving fruit flies your cancer’s mutations could guide your treatment on May 22, 2019 at 11:16 am
The team sequenced the DNA of tumour cells in his blood and could not identify the mutations ... already offers this testing service to people with cancer. When a person has a tumour removed, a small ... […]
- TGen-Ethos underscore need for setting high standards in veterinary cancer diagnostics on May 22, 2019 at 9:40 am
TGen conducted genetic analysis of more than 180 dogs with naturally occurring cancer to confirm ... transparency. Each lab has their own methods for how to run the same test," said Dr. Chand ... […]
- Revolutionising care for prostate cancer patients on May 22, 2019 at 5:24 am
The pioneering development gives men access to view their PSA blood test results ... affected even if their test results were abnormal. Alison Richardson, Professor in Cancer Nursing and End ... […]
- Officer learns of cancer after blood donation visit on May 21, 2019 at 9:37 am
According to the National Cancer Institute at the National Institute of Heath ... Usually CLL does not cause any signs or symptoms and is found during a routine blood test. “So I found out [about my ... […]
- AI for lung cancer screening & Gottlieb on CBD on May 21, 2019 at 9:25 am
As DNA ancestry sites gather more data, the answer for consumers often… MIT professor is accused of claiming others’ scientific discoveries… MIT professor is accused of claiming others’ scientific ... […]
- Cancer: Using 3D to test personalized treatments in five days on May 21, 2019 at 7:39 am
"Not only does a tumour develop in 3D, but it also contains other types of cells, such as fibroblasts (tissues) and endothelial cells (blood vessels ... (2019, May 21). Cancer: Using 3D to test ... […]
- Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel on May 21, 2019 at 6:00 am
REHOVOT, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB:TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of ... […]
- New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon® Blood Test on May 19, 2019 at 9:30 am
Dr. Deshpande’s colleagues presented the data today in a poster titled “Increasing uptake of colon cancer screening in a medically underserved population with the addition of blood-based ... […]
- Ovarian cancer is deadly, but new tests, treatments start to emerge on May 18, 2019 at 2:53 pm
Lee says. The medical school curriculum change is a sign that the subject of ovarian cancer is being taken more seriously. It's part of a surge of hopeful recent advances, including new research on ... […]
via Bing News